These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 5141034

  • 1. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E, Schwartze G.
    Z Gesamte Inn Med; 1971 Nov 15; 26(22):710-6. PubMed ID: 5141034
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of porphyria cutanea tarda by venesection.
    Ramsay CA, Magnus IA, Turnbull A, Baker H.
    Q J Med; 1974 Jan 15; 43(169):1-24. PubMed ID: 4822971
    [No Abstract] [Full Text] [Related]

  • 3. Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals.
    Walsh JR, Lobitz WC, Mahler DJ, Kingery FA.
    Arch Dermatol; 1970 Feb 15; 101(2):167-72. PubMed ID: 5413253
    [No Abstract] [Full Text] [Related]

  • 4. Porphyria cutanea tarda in association with hemosiderosis of the liver. Iron absorption studies and evaluation of therapy by phlebotomy.
    Strickland GT.
    Am J Gastroenterol; 1968 Sep 15; 50(3):202-7. PubMed ID: 5677557
    [No Abstract] [Full Text] [Related]

  • 5. Porphyria cutanea tarda. New facts on aetiology, pathogenesis clinical manifestations and treatment.
    Malina L, Chlumský J, Chlumská A.
    Acta Univ Carol Med Monogr; 1974 Sep 15; (59):1-126. PubMed ID: 4616623
    [No Abstract] [Full Text] [Related]

  • 6. Porphyria cutanea tarda in an 8-year-old boy.
    Welland FH, Carlsen RA.
    Arch Dermatol; 1969 Apr 15; 99(4):451-4. PubMed ID: 5769329
    [No Abstract] [Full Text] [Related]

  • 7. Porphyria cutanea tarda treated by repeated venesection: clinical and biochemical response.
    Baker H, Turnbull A.
    Proc R Soc Med; 1969 Jun 15; 62(6):590-2. PubMed ID: 5802737
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Porphyria cutanea tarda: role of iron.
    Sachson RA.
    N Engl J Med; 1969 Feb 13; 280(7):387. PubMed ID: 5762593
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores.
    Lundvall O.
    Acta Med Scand; 1971 Feb 13; 189(1-2):33-49. PubMed ID: 5121531
    [No Abstract] [Full Text] [Related]

  • 18. [Results of clinical and chemical studies in porphyria cutanea tarda].
    Formanek I, Niebauer G.
    Wien Z Inn Med; 1966 Nov 13; 47(11):438-44. PubMed ID: 6005177
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and biological effects of chelating agents in porphyria cutanea tarda].
    Thivolet J, Perrot H, Mallein R, Sabater P.
    Presse Med (1893); 1968 Feb 17; 76(8):367-70. PubMed ID: 4967022
    [No Abstract] [Full Text] [Related]

  • 20. Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda.
    Felsher BF, Jones ML, Redeker AG.
    JAMA; 1973 Nov 05; 226(6):663-5. PubMed ID: 4800611
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.